Press Releases
15.05.2026
Biorce to Host Leading Experts at “The End. of Clinical Trials as We Knew Them” Boston Edition
Biorce is set to make its mark with a bold new conference experience, as the life sciences industry gathers in Boston for a landmark week of events.

© Omni Boston Hotel at the Seaport
As the life sciences industry gathers in Boston for a landmark week of events alongside SCOPE Summit and Bio-IT World, Biorce is set to make its mark with a bold new conference experience. The AI healthtech startup will bring together leading voices through a provocative event concept designed to challenge conventional thinking around the future of clinical trials.
Boston, Massachusetts, United States - [May 15, 2026] - Biorce will bring together some of the world’s leading voices in clinical innovation, artificial intelligence, biotech, and pharmaceutical for development “The End. of Clinical Trials as We Knew Them”, taking place on May 22, 2026, at the Omni Boston Hotel at the Seaport.
Designed as a high-impact convergence for the future of clinical research, The End. Boston will convene 150 leaders from pharma, biotech, CROs, investment firms, regulatory and research organizations for a one-day immersive experience focused on how AI is reshaping clinical trial design, from protocol development to market approval.
More than a conference, The End. represents a shift. "Clinical trials are still being designed the same way they were 30 years ago. And that has to change,” added Pedro Coelho, founder and CEO of Biorce. During the event, Biorce will also unveil Aika v2.0, the company’s next-generation AI platform. Attendees will get an exclusive first look at Biorce’s newly enhanced platform that is redefining how AI supports modern clinical development with focus on automation, scientific rigor, and robust oversight.
The End. lives up to its name. The visual campaign evokes an atmosphere suspended between the clinical and the cosmic, a subtle meditation on transition and what comes next for clinical trials. As part of the broader campaign rollout, Biorce has launched a series of high-impact offline bus stop installations in the city of Boston, featuring striking visuals and cryptic messaging intended to provoke reflection, and raises the kind of questions the industry rarely asks out loud.
For more information about The End., visit: https://www.biorce.com/the-end.
About Biorce
Biorce is an AI healthtech startup, building defensible AI solutions for clinical trial development. Its platform, Aika, is a continuous intelligent layer, from protocol decision to regulatory submission, enabling fewer amendments and a dramatic reduction of cost and time.
Media contact
Lynn Caroline Broeker
PR & Media collaborations
lynn.broeker@biorce.com






